Todd Anderman sold $87K of OCUL stock

Todd Anderman, Chief Legal Officer of Ocular Therapeutix, Inc (OCUL), sold 11,984 shares of OCUL stock worth $87K, per an SEC Form 4 filed Oct 13, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 8, 2026, 5 days before it was made public.

OCUL has moved -8.8% since the trade date, from $7.51 to $6.85 (Nov 9, 2026 close).